Maximize Returns with AI-Powered HBIO Insights




HBIO Forecast

Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares Not Telling The Full Story - Simply Wall St

Finance

You may think that with a price-to-sales (or "P/S") ratio of 1.3x Harvard Bioscience, Inc. (NASDAQ:HBIO) is definitely a stock worth checking out, seeing as almost half of all the Life Sciences companies in the United States have P/S ratios greater than 3.3x and even P/S above 6x aren't out of the ordinary. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.

simplywall.st     Jul 15, 2024